DrugDashboards

Cefdinir

Cefdinir · CEFDINIR MONOHYDRATE 250 mg/5mL · Powder, For Suspension · Oral · Proficient Rx LP

NDC 63187-0616-00 · 100 mL in 1 BOTTLE · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for cefdinir (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA065332
TE code
AB
Approval date
May 4, 2007
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Cefdinir (Powder, For Suspension)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsCEFDINIR 250 mg/5mLJul 15, 2026Sep 3, 2026
Direct RxCEFDINIR 250 mg/5mLJul 15, 2026Sep 3, 2026
NuCare Pharmaceuticals, Inc.CEFDINIR 125 mg/5mLJul 15, 2026Sep 3, 2026
NuCare Pharmaceuticals,Inc.CEFDINIR 250 mg/5mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsCEFDINIR MONOHYDRATE 250 mg/5mLAug 26, 2026Sep 2, 2026
Ascend Laboratories, LLCCEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedCEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedCEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Direct RxCEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.CEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.CEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, Inc.CEFDINIR MONOHYDRATE 125 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.CEFDINIR MONOHYDRATE 250 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.CEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.CEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Proficient Rx LPCEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Proficient Rx LPCEFDINIR MONOHYDRATE 250 mg/5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CEFDINIR MONOHYDRATE 250 mg/5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CEFDINIR MONOHYDRATE 125 mg/5mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.CEFDINIR 125 mg/5mLJul 15, 2026Aug 31, 2026
Proficient Rx LPCEFDINIR 250 mg/5mLJul 15, 2026Aug 31, 2026
A-S Medication SolutionsCEFDINIR 125 mg/5mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cefdinir — NDC 63187-0616-00," retrieved September 3, 2026, https://drugdashboards.com/drug/63187061600.

Free to cite with attribution — see how the data is put together.